TY - JOUR AU - Afshar-Oromieh, A. AU - Malcher, A. AU - Eder, M. AU - Eisenhut, M. AU - Linhart, H. G. AU - Hadaschik, B. A. PY - 2013 DA - 2013// TI - PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-012-2298-2 DO - 10.1007/s00259-012-2298-2 ID - Afshar-Oromieh2013 ER - TY - JOUR AU - Perera, M. AU - Papa, N. AU - Christidis, D. AU - Wetherell, D. AU - Hofman, M. S. AU - Murphy, D. G. PY - 2016 DA - 2016// TI - Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.06.021 DO - 10.1016/j.eururo.2016.06.021 ID - Perera2016 ER - TY - JOUR AU - Eiber, M. AU - Maurer, T. AU - Souvatzoglou, M. AU - Beer, A. J. AU - Ruffani, A. AU - Haller, B. PY - 2015 DA - 2015// TI - Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.154153 DO - 10.2967/jnumed.115.154153 ID - Eiber2015 ER - TY - JOUR AU - Fendler, W. P. AU - Calais, J. AU - Eiber, M. AU - Flavell, R. R. AU - Mishoe, A. AU - Feng, F. Y. PY - 2019 DA - 2019// TI - Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial JO - JAMA Oncol VL - 5 UR - https://doi.org/10.1001/jamaoncol.2019.0096 DO - 10.1001/jamaoncol.2019.0096 ID - Fendler2019 ER - TY - JOUR AU - Rauscher, I. AU - Maurer, T. AU - Beer, A. J. AU - Graner, F. -. P. AU - Haller, B. AU - Weirich, G. PY - 2016 DA - 2016// TI - Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.116.173492 DO - 10.2967/jnumed.116.173492 ID - Rauscher2016 ER - TY - STD TI - Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, et al. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging [Internet]. 2017;44:1258–68. https://doi.org/https://doi.org/10.1007/s00259-017-3711-7 ID - ref6 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Avtzi, E. AU - Giesel, F. L. AU - Holland-Letz, T. AU - Linhart, H. G. AU - Eder, M. PY - 2015 DA - 2015// TI - The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-014-2949-6 DO - 10.1007/s00259-014-2949-6 ID - Afshar-Oromieh2015 ER - TY - JOUR AU - Maurer, T. AU - Gschwend, J. E. AU - Rauscher, I. AU - Souvatzoglou, M. AU - Haller, B. AU - Weirich, G. PY - 2016 DA - 2016// TI - Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer JO - J Urol VL - 195 UR - https://doi.org/10.1016/j.juro.2015.12.025 DO - 10.1016/j.juro.2015.12.025 ID - Maurer2016 ER - TY - JOUR AU - Fendler, W. P. AU - Schmidt, D. F. AU - Wenter, V. AU - Thierfelder, K. M. AU - Zach, C. AU - Stief, C. PY - 2016 DA - 2016// TI - 68Ga-PSMA PET/CT detects the location and extent of primary prostate cancer JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.116.172627 DO - 10.2967/jnumed.116.172627 ID - Fendler2016 ER - TY - JOUR AU - Herlemann, A. AU - Wenter, V. AU - Kretschmer, A. AU - Thierfelder, K. M. AU - Bartenstein, P. AU - Faber, C. PY - 2016 DA - 2016// TI - (68)Ga-PSMA positron emission tomography/computed tomography provides accurate staging of lymph node regions prior to lymph node dissection in patients with prostate cancer JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2015.12.051 DO - 10.1016/j.eururo.2015.12.051 ID - Herlemann2016 ER - TY - JOUR AU - Leeuwen, P. J. AU - Emmett, L. AU - Ho, B. AU - Delprado, W. AU - Ting, F. AU - Nguyen, Q. PY - 2017 DA - 2017// TI - Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer JO - BJU Int VL - 119 UR - https://doi.org/10.1111/bju.13540 DO - 10.1111/bju.13540 ID - Leeuwen2017 ER - TY - JOUR AU - Hofman, M. S. AU - Lawrentschuk, N. AU - Francis, R. J. AU - Tang, C. AU - Vela, I. AU - Thomas, P. PY - 2020 DA - 2020// TI - Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study JO - Lancet (London, England) VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30314-7 DO - 10.1016/S0140-6736(20)30314-7 ID - Hofman2020 ER - TY - JOUR AU - Giesel, F. L. AU - Fiedler, H. AU - Stefanova, M. AU - Sterzing, F. AU - Rius, M. AU - Kopka, K. PY - 2015 DA - 2015// TI - PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3106-6 DO - 10.1007/s00259-015-3106-6 ID - Giesel2015 ER - TY - JOUR AU - Pyka, T. AU - Okamoto, S. AU - Dahlbender, M. AU - Tauber, R. AU - Retz, M. AU - Heck, M. PY - 2016 DA - 2016// TI - Comparison of bone scintigraphy and (68)Ga-PSMA PET for skeletal staging in prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 43 UR - https://doi.org/10.1007/s00259-016-3435-0 DO - 10.1007/s00259-016-3435-0 ID - Pyka2016 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Zechmann, C. M. AU - Malcher, A. AU - Eder, M. AU - Eisenhut, M. AU - Linhart, H. G. PY - 2014 DA - 2014// TI - Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-013-2525-5 DO - 10.1007/s00259-013-2525-5 ID - Afshar-Oromieh2014 ER - TY - JOUR AU - Rowe, S. P. AU - Macura, K. J. AU - Mena, E. AU - Blackford, A. L. AU - Nadal, R. AU - Antonarakis, E. S. PY - 2016 DA - 2016// TI - PSMA-Based [(18)F]DCFPyL PET/CT is superior to conventional imaging for lesion detection in patients with metastatic prostate cancer JO - Mol Imaging Biol VL - 18 UR - https://doi.org/10.1007/s11307-016-0957-6 DO - 10.1007/s11307-016-0957-6 ID - Rowe2016 ER - TY - JOUR AU - Giesel, F. L. AU - Hadaschik, B. AU - Cardinale, J. AU - Radtke, J. AU - Vinsensia, M. AU - Lehnert, W. PY - 2017 DA - 2017// TI - F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-016-3573-4 DO - 10.1007/s00259-016-3573-4 ID - Giesel2017 ER - TY - JOUR AU - Rauscher, I. AU - Maurer, T. AU - Fendler, W. P. AU - Sommer, W. H. AU - Schwaiger, M. AU - Eiber, M. PY - 2016 DA - 2016// TI - (68)Ga-PSMA ligand PET/CT in patients with prostate cancer: how we review and report JO - Cancer Imaging VL - 16 UR - https://doi.org/10.1186/s40644-016-0072-6 DO - 10.1186/s40644-016-0072-6 ID - Rauscher2016 ER - TY - STD TI - Sheikhbahaei S, Afshar-Oromieh A, Eiber M, Solnes LB, Javadi MS, Ross AE, et al. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. Eur J Nucl Med Mol Imaging [Internet]. 2017;44:2117–36. Doi:https://doi.org/https://doi.org/10.1007/s00259-017-3780-7 ID - ref19 ER - TY - JOUR AU - Rowe, S. P. AU - Deville, C. AU - Paller, C. AU - Cho, S. Y. AU - Fishman, E. K. AU - Pomper, M. G. PY - 2015 DA - 2015// TI - Uptake of (18)F-DCFPyL in Paget’s disease of bone, an important potential pitfall in clinical interpretation of PSMA PET studies JO - Tomography VL - 1 UR - https://doi.org/10.18383/j.tom.2015.00169 DO - 10.18383/j.tom.2015.00169 ID - Rowe2015 ER - TY - JOUR AU - Werner, R. A. AU - Sheikhbahaei, S. AU - Jones, K. M. AU - Javadi, M. S. AU - Solnes, L. B. AU - Ross, A. E. PY - 2017 DA - 2017// TI - Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted (18)F-DCFPyL in peripheral ganglia JO - Ann Nucl Med VL - 31 UR - https://doi.org/10.1007/s12149-017-1201-4 DO - 10.1007/s12149-017-1201-4 ID - Werner2017 ER - TY - JOUR AU - Rischpler, C. AU - Beck, T. I. AU - Okamoto, S. AU - Schlitter, A. M. AU - Knorr, K. AU - Schwaiger, M. PY - 2018 DA - 2018// TI - (68)Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging JO - J Nucl Med VL - 59 UR - https://doi.org/10.2967/jnumed.117.204677 DO - 10.2967/jnumed.117.204677 ID - Rischpler2018 ER - TY - JOUR AU - Hofman, M. S. AU - Hicks, R. J. AU - Maurer, T. AU - Eiber, M. PY - 2018 DA - 2018// TI - Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls JO - Radiographics VL - 38 UR - https://doi.org/10.1148/rg.2018170108 DO - 10.1148/rg.2018170108 ID - Hofman2018 ER - TY - STD TI - Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, et al. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2020. ID - ref24 ER - TY - JOUR AU - Giesel, F. L. AU - Knorr, K. AU - Spohn, F. AU - Will, L. AU - Maurer, T. AU - Flechsig, P. PY - 2019 DA - 2019// TI - Detection efficacy of (18)F-PSMA-1007 PET/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy JO - J Nucl Med VL - 60 UR - https://doi.org/10.2967/jnumed.118.212233 DO - 10.2967/jnumed.118.212233 ID - Giesel2019 ER - TY - JOUR AU - Rahbar, K. AU - Afshar-Oromieh, A. AU - Seifert, R. AU - Wagner, S. AU - Schäfers, M. AU - Bögemann, M. PY - 2018 DA - 2018// TI - Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 45 UR - https://doi.org/10.1007/s00259-018-4089-x DO - 10.1007/s00259-018-4089-x ID - Rahbar2018 ER - TY - JOUR AU - Kuten, J. AU - Fahoum, I. AU - Savin, Z. AU - Shamni, O. AU - Gitstein, G. AU - Hershkovitz, D. PY - 2020 DA - 2020// TI - Head-to-head comparison of (68)Ga-PSMA-11 with (18)F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234187 DO - 10.2967/jnumed.119.234187 ID - Kuten2020 ER - TY - JOUR AU - Rauscher, I. AU - Krönke, M. AU - König, M. AU - Gafita, A. AU - Maurer, T. AU - Horn, T. PY - 2020 DA - 2020// TI - Matched-pair comparison of (68)Ga-PSMA-11 PET/CT and (18)F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.229187 DO - 10.2967/jnumed.119.229187 ID - Rauscher2020 ER - TY - JOUR AU - Sathianathen, N. J. AU - Konety, B. R. AU - Crook, J. AU - Saad, F. AU - Lawrentschuk, N. PY - 2018 DA - 2018// TI - Landmarks in prostate cancer JO - Nat Rev Urol VL - 15 UR - https://doi.org/10.1038/s41585-018-0060-7 DO - 10.1038/s41585-018-0060-7 ID - Sathianathen2018 ER - TY - JOUR AU - Eiber, M. AU - Herrmann, K. AU - Calais, J. AU - Hadaschik, B. AU - Giesel, F. L. AU - Hartenbach, M. PY - 2018 DA - 2018// TI - Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-Ligand PET/CT JO - J Nucl Med VL - 59 UR - https://doi.org/10.2967/jnumed.117.198119 DO - 10.2967/jnumed.117.198119 ID - Eiber2018 ER - TY - STD TI - Rowe SP, Pienta KJ, Pomper MG, Gorin MA. Proposal for a structured reporting system for prostate-specific membrane antigen-targeted PET imaging: PSMA-RADS Version 1.0. J Nucl Med. 2018;59:479–85. ID - ref31 ER - TY - STD TI - Rowe SP, Pienta KJ, Pomper MG, Gorin MA. PSMA-RADS Version 1.0: A step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies. Eur Urol. 2018;73:485–7. ID - ref32 ER - TY - JOUR AU - Chiu, L. W. AU - Lawhn-Heath, C. AU - Behr, S. C. AU - Juarez, R. AU - Perez, P. M. AU - Lobach, I. PY - 2020 DA - 2020// TI - Factors predicting metastatic disease in (68)Ga-PSMA-11 PET-positive osseous lesions in prostate cancer JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.241174 DO - 10.2967/jnumed.119.241174 ID - Chiu2020 ER - TY - STD TI - Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Leal JP, Higuchi T, et al. Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on (18)F-DCFPyL PET/CT imaging. J Nucl Med. 2018;59:1857–64. ID - ref34 ER - TY - JOUR AU - Demirci, E. AU - Akyel, R. AU - Caner, B. AU - Alan-Selçuk, N. AU - Güven-Meşe, Ş. AU - Ocak, M. PY - 2020 DA - 2020// TI - Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria JO - Nucl Med Commun VL - 41 UR - https://doi.org/10.1097/MNM.0000000000001219 DO - 10.1097/MNM.0000000000001219 ID - Demirci2020 ER - TY - STD TI - Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico A V, Davis BJ, Dorff T, et al. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:479–505. ID - ref36 ER - TY - STD TI - Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. (68)Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44:1014–24. ID - ref37 ER - TY - JOUR AU - Preisser, F. AU - Chun, F. K. H. AU - Pompe, R. S. AU - Heinze, A. AU - Salomon, G. AU - Graefen, M. PY - 2019 DA - 2019// TI - Persistent prostate-specific antigen after radical prostatectomy and its impact on oncologic outcomes JO - Eur Urol VL - 76 UR - https://doi.org/10.1016/j.eururo.2019.01.048 DO - 10.1016/j.eururo.2019.01.048 ID - Preisser2019 ER - TY - JOUR AU - Bubendorf, L. AU - Schöpfer, A. AU - Wagner, U. AU - Sauter, G. AU - Moch, H. AU - Willi, N. PY - 2000 DA - 2000// TI - Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients JO - Hum Pathol VL - 31 UR - https://doi.org/10.1053/hp.2000.6698 DO - 10.1053/hp.2000.6698 ID - Bubendorf2000 ER - TY - STD TI - Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618–29. ID - ref40 ER - TY - JOUR AU - Yin, Y. AU - Werner, R. A. AU - Higuchi, T. AU - Lapa, C. AU - Pienta, K. J. AU - Pomper, M. G. PY - 2019 DA - 2019// TI - Follow-up of lesions with equivocal radiotracer uptake on PSMA-targeted PET in patients with prostate cancer: predictive values of the PSMA-RADS-3A and PSMA-RADS-3B categories JO - J Nucl Med VL - 60 UR - https://doi.org/10.2967/jnumed.118.217653 DO - 10.2967/jnumed.118.217653 ID - Yin2019 ER - TY - JOUR AU - Dietlein, F. AU - Kobe, C. AU - Hohberg, M. AU - Zlatopolskiy, B. D. AU - Krapf, P. AU - Endepols, H. PY - 2020 DA - 2020// TI - Intraindividual comparison of (18)F-PSMA-1007 with renally excreted PSMA ligands for PSMA PET imaging in patients with relapsed prostate cancer JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234898 DO - 10.2967/jnumed.119.234898 ID - Dietlein2020 ER - TY - JOUR AU - Wu, J. S. AU - Goldsmith, J. D. AU - Horwich, P. J. AU - Shetty, S. K. AU - Hochman, M. G. PY - 2008 DA - 2008// TI - Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy? JO - Radiology VL - 248 UR - https://doi.org/10.1148/radiol.2483071742 DO - 10.1148/radiol.2483071742 ID - Wu2008 ER -